Molecular regulation of the renin-angiotensin system by sodium-glucose cotransporter 2 inhibition in type 1 diabetes mellitus

Diabetologia. 2019 Jun;62(6):1090-1093. doi: 10.1007/s00125-019-4871-8. Epub 2019 Apr 11.

¹ School of Medical Sciences, Faculty of Medicine, UNSW Sydney, Level 2 Lowy Cancer Research Centre, High Street Gate 9, Sydney, NSW, 2052, Australia. c.kopecky@unsw.edu.au.
² Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria. c.kopecky@unsw.edu.au.
³ Department of Medicine, Division of Nephrology, Toronto General Hospital, University of Toronto, Toronto, ON, Canada.
⁴ Attoquant Diagnostics, Vienna, Austria.
⁵ Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria.
⁶ Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
⁷ School of Medical Sciences, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia.
⁸ 6th Medical Department for Nephrology and Dialysis, Wilhelminenhospital, Vienna, Austria.
⁹ Sigmund Freud Private University, Medical School, Vienna, Austria.

No abstract available

Keywords: Angiotensins; Diabetes mellitus; Empagliflozin; Renin–angiotensin system activation; SGLT-2 inhibition.

Publication types